FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:1998-1999 June 20, 2002 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rosenwald, A. PubMed Citation

The utility of disease classifications depends greatly on the tools used. The lower the resolving power, the more subjective and controversial the interpretation. As has been the case throughout the history of lymphoma taxonomy, this often leads to a plethora of classification schemes, with resultant confusion and miscommunication. Yet diagnostic precision is an essential foundation for effective therapy, since individual diseases might be expected, in general, to require individual therapeutic approaches. Unfortunately, in the field of cancer, the weaknesses inherent in a purely histologic diagnosis, the primary classification tool used for most of the 20th century, have often led to . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Wang, S. S., Cerhan, J. R., Hartge, P., Davis, S., Cozen, W., Severson, R. K., Chatterjee, N., Yeager, M., Chanock, S. J., Rothman, N. (2006). Common Genetic Variants in Proinflammatory and Other Immunoregulatory Genes and Risk for Non-Hodgkin Lymphoma. Cancer Res. 66: 9771-9780 [Abstract] [Full Text]